BDX - Becton, Dickinson and Company

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $173.19 DETAILS

Stock News

BD Launches Elyra Thulium Fiber Laser System for Kidney Stone Care

BDX launches the Elyra Thulium Fiber Laser system to streamline kidney stone care and boost workflow flexibility for urology teams.

May 22, 2026 07:16 AM • zacks.com

BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System

New laser system is designed to help urology teams enhance efficiency, versatility, and procedural workflow across stone management and soft tissue procedures. FRANKLIN LAKES, N.J.

May 21, 2026 02:50 AM • prnewswire.com

Peter Menziuso Named EVP and President, BD Interventional

FRANKLIN LAKES, N.J., May 18, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective June 1.

May 18, 2026 02:50 AM • prnewswire.com

AI, Robotics Key to Transforming Health Care: BD CEO

Tom Polen, CEO of medical technology company BD, says that in the next decade AI and robotics will transform health care in ways that will make today's system seem archaic. Polen sits down with Bloomberg's Caroline Hyde on the sidelines of the Consello Spark Summit.

May 15, 2026 06:36 AM • youtube.com

Becton, Dickinson and Company (BDX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

May 12, 2026 01:20 PM • seekingalpha.com

Is Becton Dickinson & Co (BDX) a Bargain After 4.2% Drop? GF Value Says Undervalued

On May 11, 2026, Becton Dickinson and Co (BDX) shares fell 4.2% today, closing at $143.15. This decline continues a downward trend over the past month, where the

May 11, 2026 04:02 PM • gurufocus.com

Becton, Dickinson and Company Q2 Earnings Call Highlights

Becton, Dickinson and Company NYSE: BDX reported fiscal second-quarter revenue and adjusted earnings ahead of its internal expectations, while management raised its full-year adjusted earnings outlook and said growth was broad-based across most of the portfolio.

May 09, 2026 06:09 AM • marketbeat.com

Is the Options Market Predicting a Spike in Becton Dickinson Stock?

Investors need to pay close attention to BDX stock based on the movements in the options market lately.

May 07, 2026 12:05 PM • zacks.com

BD Stock Up in Pre-Market Post Q2 Earnings & Revenue Beat, Margins Up

BDX beats second-quarter fiscal 2026 earnings and revenue estimates, driven by broad segment strength and improved profitability.

May 07, 2026 07:35 AM • zacks.com

Becton, Dickinson and Company (BDX) Q2 2026 Earnings Call Transcript

May 07, 2026 07:21 AM • seekingalpha.com

Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q2 Earnings

While the top- and bottom-line numbers for Becton Dickinson (BDX) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

May 07, 2026 06:31 AM • zacks.com

Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates

Becton Dickinson (BDX) came out with quarterly earnings of $2.9 per share, beating the Zacks Consensus Estimate of $2.77 per share. This compares to earnings of $3.35 per share a year ago.

May 07, 2026 04:46 AM • zacks.com

Becton Dickinson raises annual profit forecast on strength in drug delivery devices

Becton Dickinson raised its annual profit forecast on Thursday, riding strong demand for its drug-delivery devices and surgical equipment, and appointed Vitor Roque as its chief financial officer.

May 07, 2026 03:57 AM • reuters.com

BD Appoints Vitor Roque Chief Financial Officer

FRANKLIN LAKES, N.J., May 7, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Vitor Roque has been named executive vice president and chief financial officer (CFO), effective May 7.

May 07, 2026 02:31 AM • prnewswire.com

BD Reports Second Quarter Fiscal 2026 Financial Results

Revenue of $4.7 billion increased 5.2% as reported, 2.6% FXN GAAP and adjusted diluted EPS from continuing operations of $(0.13) and $2.90, respectively Executed a $2.0 billion accelerated share repurchase (ASR) program and retired $2.1 billion of debt in the quarter Company reaffirms revenue growth guidance, raises full-year adjusted diluted EPS guidance1 FRANKLIN LAKES, N.J., May 7, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 second quarter, which ended March 31, 2026.

May 07, 2026 02:30 AM • prnewswire.com

Seeking Clues to Becton Dickinson (BDX) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Becton Dickinson (BDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.

May 05, 2026 06:16 AM • zacks.com

BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI

By integrating the BD Pyxis™ Pro and BD Alaris™ platforms, Wellstar Health System is giving clinicians clearer insight, greater accuracy and simple automation, so they can focus on delivering safer, more consistent care to every patient FRANKLIN LAKES, N.J. and MARIETTA, Ga.

May 05, 2026 02:50 AM • prnewswire.com

Madison Small Cap Fund Q1 2026 Portfolio Activity

ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry and has been growing revenue at a low double-digit compound annual growth rate over the past several years. Madison Small Cap Fund liquidated its position in Globus Medical after a multi-year period because the company's success drove its market cap to $12B.

May 04, 2026 06:35 PM • seekingalpha.com

Can Sustained Product Momentum Drive BDX Stock Before Q2 Earnings?

BD rides on Medical and Interventional product momentum, but China dynamics and research funding could weigh on second-quarter fiscal 2026 results.

May 04, 2026 10:50 AM • zacks.com

Earnings Preview: Becton Dickinson (BDX) Q2 Earnings Expected to Decline

Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apr 30, 2026 07:06 AM • zacks.com